在患有异常性颗粒性乳腺炎的患者中单独使用甲状腺素治疗的影响
Mehmet Nur Kaya1, Emre Tekgöz1, Seda Çolak1
1Rheumatology Department, Gülhane Training and Research Hospital, Ankara, Türkiye.
Postgraduate medicine
|May 5, 2025
概括
甲托雷克萨特治疗对异常性颗粒性乳腺炎 (IGM) 有效,可实现高缓解率. 这项研究证实了甲基甲酸盐的存在.
科学领域:
- 类风湿病学 类风湿病学
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
背景情况:
- 异常性颗粒性乳腺炎 (IGM) 是一种罕见的,慢性炎症性乳腺疾病.
- 具有颗粒瘤形成的特征,IGM需要有效的治疗策略.
研究的目的:
- 为了评估接受甲醇的IGM患者的遵守率和缓解率.
- 评估在IGM管理中甲醇的长期疗效和耐受性.
主要方法:
- 对114名活检证明的IGM患者进行了回顾性分析,这些患者接受了至少一年的甲铁酸治疗.
- 收集的数据包括人口统计,临床发现,实验室参数和治疗遵守情况.
- 卡普兰-梅尔分析被用来评估药物使用时间.
主要成果:
- 平均一年后,85.1%的患者 (97/114) 实现了完全缓解.
- 甲状腺素使用的平均持续时间约为11.24个月.
- 在IGM患者中,甲托雷克萨特治疗表现出良好的耐受性.
结论:
- 甲托雷克萨特是一种成功且耐受性良好的治疗方法,用于治疗异常性粒状乳腺炎.
- 甲索特雷克萨剂的持续时间与IGM治疗成功相关.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120